Elite Pharmaceuticals Inc NV FY 2026: Revenue $148.9M, Net income $44.9M — 10-K Summary
Elite Pharmaceuticals Inc /NV/ reported fiscal 2026 results with revenue of $148.9M, up 77% from $84M a year earlier, and net income attributable to common shareholders of $44.9M compared with a net loss of $4.3M in FY 2025.Financial HighlightsBusiness HighlightsOriginal SEC Filing: ELITE PHARMACEU…